Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Gilead Sciences in a report ...
We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...
Stock analysts at Leerink Partnrs dropped their Q2 2025 earnings estimates for shares of Encompass Health in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now ...
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...
We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...
Incorporated (NYSE: ELAN) shares have reached a 52-week low, dipping to $11.11, as the company faces a tumultuous market environment. With a market capitalization of $5.55 billion and a beta of 1.42, ...